Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers

The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.

The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.

type 1 diabetes
Reprogrammed Cells Treat Diabetes in Mice
Reprogrammed Cells Treat Diabetes in Mice
Abby Olena | May 2, 2018
Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo into β-like cells that secrete insulin and improve diabetes symptoms.
Diabetes Is Five Diseases, Not Two
Diabetes Is Five Diseases, Not Two
Jim Daley | Mar 5, 2018
The new classification system could help improve personalized medicine approaches to the disease.
Gene Therapy Temporarily Reverses Type 1 Diabetes in Mice
Gene Therapy Temporarily Reverses Type 1 Diabetes in Mice
Shawna Williams | Jan 4, 2018
Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.
Image of the Day: Glucose Sensor 
Image of the Day: Glucose Sensor 
The Scientist Staff, The Scientist Staff | Jan 2, 2018
Scientists build a biosensor skin patch for noninvasive glucose monitoring. 
Will the Noninvasive Glucose Monitoring Revolution Ever Arrive?
Will the Noninvasive Glucose Monitoring Revolution Ever Arrive?
Catherine Offord | Oct 12, 2017
A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
Immunotherapy Promising for Diabetes: Study
Immunotherapy Promising for Diabetes: Study
Aggie Mika | Aug 9, 2017
A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.
Bioengineered ‘Pancreas’ Effective in First Patient
Bioengineered ‘Pancreas’ Effective in First Patient
Aggie Mika | May 12, 2017
The diabetic volunteer continued to produce insulin one year after she received a transplant of abdominal islet cells.
Antibiotic Therapy During Infancy Increases Type 1 Diabetes Risk in Mice
Antibiotic Therapy During Infancy Increases Type 1 Diabetes Risk in Mice
Alison F. Takemura | Aug 22, 2016
Three therapeutic doses administered during early life disturb the animals’ microbiomes and lead to enduring changes in the immune systems of non-obese diabetic mice, researchers report.
Book Excerpt from <em>Blood Sugar</em>
Book Excerpt from Blood Sugar
Anthony Ryan Hatch | Jun 30, 2016
Author Anthony Ryan Hatch relays his personal experience with metabolic syndrome.